|
|
Found results for
 patents
1.
|
CELL POPULATIONS IN THE ANORECTAL TRANSITION ZONE WITH TISSUE REGENERATIVE CAPACITY, AND METHODS FOR ISOLATION AND USE THEREOF
| Application Number |
18682302 |
| Status |
Pending |
| Filing Date |
2022-08-12 |
| First Publication Date |
2024-10-10 |
| Owner |
Curileum Discovery Ltd (United Kingdom)
|
| Inventor |
- Kalra, Priti
- Moore, Jeffrey G.
|
Abstract
Provided herein are compositions of anorectal transition zone stem cells, including multipotent and progenitor cells, to treat anal fistulas, for example, refractory complex perianal fistulas associated with Crohn's disease or of unknown aetiology. Also provided are pharmaceutical compositions of the anorectal transition zone stem cells, including multipotent and progenitor cells, in a pharmaceutically acceptable carrier.
IPC Classes ?
- A61K 35/37 - Digestive system
- A61L 27/24 - Collagen
- A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
- A61L 27/38 - Animal cells
- A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
- C12N 5/071 - Vertebrate cells or tissues, e.g. human cells or tissues
|
2.
|
CELL POPULATIONS IN THE ANORECTAL TRANSITION ZONE WITH TISSUE REGENERATIVE CAPACITY, AND METHODS FOR ISOLATION AND USE THEREOF
| Application Number |
GB2024050415 |
| Publication Number |
2024/170911 |
| Status |
In Force |
| Filing Date |
2024-02-15 |
| Publication Date |
2024-08-22 |
| Owner |
CURILEUM DISCOVERY LTD (United Kingdom)
|
| Inventor |
- Moore, Jeffrey G.
- Moore, Jay A.
- Kalra, Priti
- Micalet, Auxtine
|
Abstract
Provided herein are compositions of anorectal transition zone stem cells, including multipotent and progenitor cells, to treat endodermal disease. Also provided are cellular compositions of the anorectal transition zone stem cells, including multipotent and progenitor cells, in a pharmaceutically acceptable carrier.
IPC Classes ?
- A61K 35/38 - StomachIntestineGoblet cellsOral mucosaSaliva
- A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 1/18 - Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A61P 11/00 - Drugs for disorders of the respiratory system
- C12N 5/071 - Vertebrate cells or tissues, e.g. human cells or tissues
|
3.
|
CELL POPULATIONS IN THE ANORECTAL TRANSITION ZONE WITH TISSUE REGENERATIVE CAPACITY, AND METHODS FOR ISOLATION AND USE THEREOF
| Application Number |
GB2024050416 |
| Publication Number |
2024/170912 |
| Status |
In Force |
| Filing Date |
2024-02-15 |
| Publication Date |
2024-08-22 |
| Owner |
CURILEUM DISCOVERY LTD (United Kingdom)
|
| Inventor |
- Moore, Jeffrey G.
- Moore, Jay A.
- Kalra, Priti
- Micalet, Auxtine
|
Abstract
Provided herein are compositions of anorectal transition zone stem cells, including multipotent and progenitor cells, to treat mesodermal disease. Also provided are cellular compositions of the anorectal transition zone stem cells, including multipotent and progenitor cells, in a pharmaceutically acceptable carrier.
IPC Classes ?
- A61K 35/38 - StomachIntestineGoblet cellsOral mucosaSaliva
- A61P 9/00 - Drugs for disorders of the cardiovascular system
- A61P 13/12 - Drugs for disorders of the urinary system of the kidneys
- A61P 19/02 - Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
- C12N 5/071 - Vertebrate cells or tissues, e.g. human cells or tissues
|
4.
|
CELL POPULATIONS IN THE ANORECTAL TRANSITION ZONE WITH TISSUE REGENERATIVE CAPACITY, AND METHODS FOR ISOLATION AND USE THEREOF
| Application Number |
GB2024050417 |
| Publication Number |
2024/170913 |
| Status |
In Force |
| Filing Date |
2024-02-15 |
| Publication Date |
2024-08-22 |
| Owner |
CURILEUM DISCOVERY LTD (United Kingdom)
|
| Inventor |
- Moore, Jeffrey G.
- Moore, Jay A.
- Kalra, Priti
- Micalet, Auxtine
|
Abstract
Provided herein are compositions of anorectal transition zone stem cells, including multipotent and progenitor cells, to treat damaged or dysfunctional ectodermal tissue. Also provided are cellular compositions of the anorectal transition zone stem cells, including multipotent and progenitor cells, in a pharmaceutically acceptable carrier.
IPC Classes ?
- A61K 35/38 - StomachIntestineGoblet cellsOral mucosaSaliva
- A61P 17/00 - Drugs for dermatological disorders
- A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
- C12N 5/071 - Vertebrate cells or tissues, e.g. human cells or tissues
|
5.
|
CELL POPULATIONS IN THE ANORECTAL TRANSITION ZONE WITH TISSUE REGENERATIVE CAPACITY, AND METHODS FOR ISOLATION AND USE THEREOF
| Application Number |
IB2022000456 |
| Publication Number |
2023/017316 |
| Status |
In Force |
| Filing Date |
2022-08-12 |
| Publication Date |
2023-02-16 |
| Owner |
CURILEUM DISCOVERY LTD (United Kingdom)
|
| Inventor |
- Kalra, Priti
- Moore, Jeffrey, G.
|
Abstract
Provided herein are compositions of anorectal transition zone stem cells, including multipotent and progenitor cells, to treat anal fistulas, for example, refractory complex perianal fistulas associated with Crohn's disease or of unknown aetiology. Also provided are pharmaceutical compositions of the anorectal transition zone stem cells, including multipotent and progenitor cells, in a pharmaceutically acceptable carrier.
IPC Classes ?
- A61K 35/37 - Digestive system
- A61K 35/545 - Embryonic stem cellsPluripotent stem cellsInduced pluripotent stem cellsUncharacterised stem cells
- A61K 35/36 - SkinHairNailsSebaceous glandsCerumenEpidermisEpithelial cellsKeratinocytesLangerhans cellsEctodermal cells
- A61L 26/00 - Chemical aspects of, or use of materials for, liquid bandages
- A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
|
6.
|
CELL POPULATIONS IN THE ANORECTAL TRANSITION ZONE WITH TISSUE REGENERATIVE CAPACITY, AND METHODS FOR ISOLATION AND USE THEREOF
| Document Number |
03228956 |
| Status |
Pending |
| Filing Date |
2022-08-12 |
| Open to Public Date |
2023-02-16 |
| Owner |
CURILEUM DISCOVERY LTD (United Kingdom)
|
| Inventor |
- Kalra, Priti
- Moore, Jeffrey G.
|
Abstract
Provided herein are compositions of anorectal transition zone stem cells, including multipotent and progenitor cells, to treat anal fistulas, for example, refractory complex perianal fistulas associated with Crohn's disease or of unknown aetiology. Also provided are pharmaceutical compositions of the anorectal transition zone stem cells, including multipotent and progenitor cells, in a pharmaceutically acceptable carrier.
IPC Classes ?
- A61K 35/37 - Digestive system
- A61K 35/545 - Embryonic stem cellsPluripotent stem cellsInduced pluripotent stem cellsUncharacterised stem cells
- A61K 35/36 - SkinHairNailsSebaceous glandsCerumenEpidermisEpithelial cellsKeratinocytesLangerhans cellsEctodermal cells
- A61L 26/00 - Chemical aspects of, or use of materials for, liquid bandages
- A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
|
|
